The Brain Canada-funded FRONTIER trial showed that Nerinetide, a neuroprotective drug delivered by paramedics before hospital arrival, significantly improves outcomes for acute ischemic stroke patients.
Brain Canada funds a number of innovative stroke research projects in the basic, clinical, and translational stages that have a high potential for impact and will contribute greatly to our understanding of this cerebrovascular disease.
Brain Canada’s rigorous scientific review process gives donors and partners a trusted mechanism to ensure projects are chosen based on merit, innovation, and potential for impact.
Making a significant difference in the lives of people in Canada doesn’t happen in a vacuum. It takes a network of visionary partners committed to investing in change. As a national convenor and facilitator, Brain Canada works with partners from coast to coast to drive innovative brain research. Some of our partners in supporting stroke research include:
